| Literature DB >> 33669123 |
Jasna Suput Omladic1,2, Maja Pajek3, Urh Groselj1,2, Katarina Trebusak Podkrajsek2,4, Magdalena Avbelj Stefanija1,2, Mojca Zerjav Tansek1,2, Primoz Kotnik1,2, Tadej Battelino1,2, Darja Smigoc Schweiger1,2.
Abstract
Background and Objectives. Familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) is a rare cause of childhood hyperthyroidism. It is caused by the thyroid-stimulating hormone receptor (TSHR) gene variants. So far, only around 40 families with FNAH have been reported. Patients with activating TSHR variants demonstrated the same classical signs and symptoms of hyperthyroidism as seen in patients with Graves' disease. Since 2012, ablative therapy is recommended to avoid relapses of hyperthyroidism and its consequences. Case Presentation. We presented a young adult male patient with a novel heterozygous TSHR disease-causing variant p.Arg418Lys (c.1253G>A) in the exon 10, who presented with a mild but progressive FNAH, with a follow-up since infancy. Discussion. Constantly suppressed TSH, including during the euthyreosis in childhood and hypothyreosis after iodine ablation therapy, suggested central dysregulation of the TSH secretion.Entities:
Keywords: FNAH; TSHR; central hypothyroidism; familial non-autoimmune autosomal dominant hyperthyroidism; radioiodine ablation therapy
Year: 2021 PMID: 33669123 PMCID: PMC7996546 DOI: 10.3390/medicina57030196
Source DB: PubMed Journal: Medicina (Kaunas) ISSN: 1010-660X Impact factor: 2.430